
Skinalar-N0.025%+0.5
ACI Limited
Fluocinolone Acetonide + Neomycin Sulfate is a topical combination product containing a mid-potency corticosteroid (fluocinolone acetonide) and an aminoglycoside antibiotic (neomycin sulfate).
Fluocinolone Acetonide + Neomycin Sulfate is a topical combination product containing a mid-potency corticosteroid (fluocinolone acetonide) and an aminoglycoside antibiotic (neomycin sulfate). It is indicated for the relief of inflammatory manifestations of corticosteroid-responsive dermatoses when secondary bacterial infection is present or considered likely.
Fluocinolone Acetonide + Neomycin Sulfate is not indicated for primary bacterial skin infections without an inflammatory dermatosis (a plain topical antibiotic is preferred), for fungal or viral skin infections, or for long-term/unsupervised use on uncomplicated dermatitis where a corticosteroid alone would suffice.
Apply a thin film of Fluocinolone Acetonide + Neomycin Sulfate to the affected skin area 2 to 3 times daily, gently rubbing in. Duration is generally limited to 1–2 weeks unless a physician directs otherwise, and re-evaluation is needed if there is no improvement within that period.
Use the lowest effective amount for the shortest duration in children; see Use in Special Populations for pediatric-specific cautions.
Avoid occlusive dressings unless specifically directed by a physician, and avoid application to the face, groin, axillae, or other skin folds for prolonged periods because of increased absorption risk (see Precautions and Warnings).
Take exactly as prescribed by your physician; do not stop, extend, skip doses, or share this medicine with others without medical advice.
Local adverse effects are more common than systemic ones with Fluocinolone Acetonide + Neomycin Sulfate:
Fluocinolone Acetonide + Neomycin Sulfate is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.